Pilar Giraldo – Medical field – Lifetime achievement Award

Pilar Giraldo – Medical field – Lifetime achievement Award

Dr. Pilar Giraldo distinguished academic and researcher in the field Identification of patient-reported outcome measures and patient-reported experience measures in Gaucher disease in Spain. Dr. Pilar Giraldo Castellano appears highly suitable for the Research for Lifetime Achievement Award based on her extensive contributions and accomplishments in the field of hematology, particularly focusing on rare diseases.

🌐 Professional Profile

Educations📚📚📚

  • PhD in Medicine and accredited as a Full Professor by ANECA.
  • Master’s in Research Methodology and Molecular Oncology.
  • Coordinator of Doctorate studies at University San Jorge.
  • Research and Publications:

    • Head of research group Unit 752 of the Center for Biomedical Research Network on Rare Diseases (CIBERER).
    • Published over 140 articles in peer-reviewed journals, more than 20 book chapters, and 5 monographs.
    • Holds 5 patents related to her field.
  • Leadership in Research Projects:

    • Principal Investigator in numerous significant projects, such as the National Plan project TED2021-131518B-C32.
    • Directed more than 20 doctoral theses.
    • Led various research initiatives focusing on lysosomal diseases and other hematological conditions.
  • International Recognition and Collaboration:

    • Organized national and international congresses, including the 12th EWGGD Congress in 2016.
    • Part of the Expert Committee of the IWGGD and the Task Force on GD of the EHA.
    • Collaborates extensively with international bodies and foundations.
  • Awards and Recognition:

    • Received multiple awards for her contributions and those of her research group members at national and international congresses.
    • Recognized for her innovative work in utilizing artificial intelligence and machine learning in medical research.
  • Teaching and Mentorship:

    • Directed numerous continuing education courses for physicians.

Created educational resources and has been involved in life-long learning activities.

📝🔬Publications📝🔬

  • Elstein D, Belmatoug N, Bembi B, Deegan P, Fernandez-Sasso D, Giraldo P,
    Göker-Alpan Ö, Hughes D, Lau H, Lukina E, Revel-Vilk S, Schwartz IVD, Istaiti M, Botha J,
    Gadir N, Schenk J, Zimran A; GOS Study Group. 2024. Twelve Years of the Gaucher
    Outcomes Survey (GOS): Insights, Achievements, and Lessons Learned from a Global
    Patient Registry.J Clin Med.13-12.
  • Wallace EL, Goker-Alpan O, Wilcox WR, Holida M, Bernat J, Longo N, Linhart
    A, Hughes DA, Hopkin RJ, Tøndel C, Langeveld M, Giraldo P, Pisani A, Germain DP, Mehta
    A, Deegan PB, Molnar MJ, Ortiz D, Jovanovic A, Muriello M, Barshop BA, Kimonis V,
    Vujkovac B, Nowak A, Geberhiwot T, Kantola I, Knoll J, Waldek S, Nedd K, Karaa A, BrillAlmon E, Alon S, Chertkoff R, Rocco R, Sakov A, Warnock DG.;. 2024. Head-to-head trial
    of pegunigalsidase alfa versus agalsidase beta in patients with Fabry disease and
    deteriorating renal function: results from the 2-year randomised phase III BALANCE
    study. J Med Genet.21-61, pp.520-530.
  • Serrano-Gonzalo I, de Frutos LL, Lahoz-Gil C, Delgado-Mateos F, FernándezGalán MÁ, Morales-Conejo M, Calle-Gordo MV, Ibarretxe-Gerediaga D, MadinaveitiaOchoa A, Albarracin-Arraigosa A, Balanzat-Muñoz J, Correcher-Medina P, García-Frade LJ,
    Hernández-Rivas JM, Labbadia F, López-Dupla JM, Lozano-Almela ML, Mora-Casterá E,
    Noya-Pereira MS, Ruíz-Guinaldo MÁ, Del Mar Tormo-Díaz M, Vitoria-Miñana I, ArévaloVargas I, Andrade-Campos M, Giraldo P. Real life data: follow-up assessment on Spanish
    3
    Gaucher disease patients treated with eliglustat. TRAZELGA project.. 2023. Real life data:
    follow-up assessment on Spanish Gaucher disease patients treated with eliglustat.
    TRAZELGA project. Orphanet J Rare Dis.18-1.
  • Stanescu S, Correcher Medina P, Del Castillo FJ, Alonso Luengo O, Arto
    Millan LM, Belanger Quintana A, Camprodon Gomez M, Diez Langhetée L, Garcia Campos
    O, Matas Garcia A, Perez-Moreno J, Rubio Gribble B, Visa-Reñé N, Giraldo-Castellano P,
    O’Callaghan Gordo M. 2023. Clinical Outcomes of Patients with Chronic Neuropathic
    Form of Gaucher Disease in the Spanish Real-World Setting: A Retrospective
    Study.Biomedicines.11-10.
  • Linhart A, Dostálová G, Nicholls K, West ML, Tøndel C, Jovanovic A, Giraldo P,
    Vujkovac B, Geberhiwot T, Brill-Almon E, Alon S, Chertkoff R, Rocco R, Hughes. 2023.
    Safety and efficacy of pegunigalsidase alfa in patients with Fabry disease who were
    previously treated with agalsidase alfa: results from BRIDGE, a phase 3 open-label study.
    Orphanet J Rare Dis. 18-1, pp.332.
  • Louw VJ, Fraser I, Giraldo P 2023. Management goals of type 1 Gaucher
    disease in South Africa: An expert Delphi consensus document on good clinical
    practice.PLoS One. 18-8.
  • Esther Valero Tena; Mercedes Roca Espiau; Jose Verdu Diaz; Jordi Diaz
    Manera; Marcio Andrade Campos; Pilar Giraldo Castellano. 2023. Advantages of digital
    technology in the assessment of bone marrow involvement in Gaucher’s disease. Front Med
    (Lausanne).

Tianzhu Guan- Biological Networks – Young Scientist Award

Tianzhu Guan- Biological Networks

Dr. Tianzhu Guan distinguished academic and researcher in the field Biological Network.  Tianzhu Guan a recipient of the 2020 Excellent PhD in the “Green and Golden Phoenix Plan” in Yangzhou City, specializes in the development of nutritional foods with dual applications in medicine and nutrition. His expertise lies at the intersection of cutting-edge scientific disciplines, where he seamlessly integrates Network Science and Graph Analytics into his research. Driven by a passion for advancing food safety, he has a keen focus on the recognition and detection of food hazard factors.

In his groundbreaking work , Tianzhu Guan employs a multifaceted approach, combining molecular techniques such as Molecular Docking, Molecular Dynamic Simulation, and Quantum Chemical Calculation. These methodologies enable him to delve into the intricate molecular interactions within food components, paving the way for innovative solutions in the development of nutritionally enriched foods.

Beyond his computational prowess, He is well-versed in experimental techniques, including Molecular Biology, Western-Blot, and SDS-Page. This dual proficiency empowers him to bridge the gap between theoretical predictions and practical applications, ensuring a comprehensive understanding of the complex relationships between food and medicine.

He is a visionary researcher who not only excels in the theoretical realms of his field but also possesses the practical skills necessary for translating his findings into tangible advancements. His holistic approach to scientific inquiry positions him as a trailblazer in the realm of nutrition and food safety.

Education

He, having pursued a dedicated academic journey, holds a comprehensive educational background in Food Science and Engineering. His academic pursuits commenced with a Bachelor’s degree in Grain Engineering from Jilin Agricultural University, spanning from September 2010 to July 2014. Building upon this foundation, he advanced to earn a Master’s degree in Food Science and Engineering at Jilin University, completing the program from September 2014 to July 2016. His scholarly pursuits culminated in a PhD in Food Science and Engineering from Jilin University, where he engaged in advanced research and academic exploration from September 2016 to October 2019. This extensive and progressively specialized education equips him with a solid foundation and expertise in the intricacies of food science and engineering.

Professional Profiles:

Research Awards

He has garnered significant recognition for his impactful contributions to the field, exemplified by the prestigious Jilin Province Science and Technology Awards. In 2022, he received the second prize in the Natural Science category for his outstanding work on the Mechanism Study of Small Molecule Disruptors in Regulating Estrogen Receptors, demonstrating a keen understanding of the intricate molecular processes involved. Prior to this achievement, in 2020, he secured another second prize in the Natural Science category for his research titled Evaluation of endocrine disrupting effects and residual detection of typical persistent organic pollutants based on receptor recognition. His consistent success in earning accolades underscores his expertise and dedication to advancing scientific knowledge in the domain of endocrine disruption and receptor recognition, further solidifying his position as a distinguished contributor to the field of science and technology.

Funding

⚫ Natural Science Fund for Colleges and Universities in Jiangsu Province of China
(Grant No. 20KJB550002)
⚫ National Youth Talent Sup- port Program of the China Association for Science
and Technology (Grant No. 20220615ZZ07110388)
⚫ Natural Science Foundation of Jiangsu Province, China (Grant No.
BK20200954)
⚫ Laboratory of Xinjiang Native Medicinal and Edible Plant Resources Chemistry,
Kashi University (Grant No. KSUZDSYS202305) Skills

Publication